Susannah Brock

4.7k total citations
6 papers, 164 citations indexed

About

Susannah Brock is a scholar working on Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Surgery. According to data from OpenAlex, Susannah Brock has authored 6 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Radiology, Nuclear Medicine and Imaging, 1 paper in Organic Chemistry and 1 paper in Surgery. Recurrent topics in Susannah Brock's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Neonatal and fetal brain pathology (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Susannah Brock is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Neonatal and fetal brain pathology (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Susannah Brock collaborates with scholars based in United Kingdom, Australia and Switzerland. Susannah Brock's co-authors include Tanja Zigova, Roy A.E. Bakay, Marla B. Luskin, Ranjita Betarbet, U. Drews, Matthias Oppitz, Volker Möbus, Tim Illidge, Noel W. Clarke and Syed A. Hussain and has published in prestigious journals such as Journal of Clinical Oncology, Developmental Biology and European Journal of Cancer.

In The Last Decade

Susannah Brock

6 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susannah Brock United Kingdom	5	72	64	63	27	23	6	164
Céline Haton France	10	81 1.1×	43 0.7×	188 3.0×	35 1.3×	37 1.6×	11	284
Regan Hamel United Kingdom	7	42 0.6×	31 0.5×	80 1.3×	8 0.3×	7 0.3×	10	175
Leif A. Droms United States	2	90 1.3×	31 0.5×	150 2.4×	16 0.6×	17 0.7×	2	239
Anne Dorothée Schmitt Germany	6	43 0.6×	28 0.4×	51 0.8×	34 1.3×	4 0.2×	7	175
Christopher Halfpenny United Kingdom	7	54 0.8×	51 0.8×	48 0.8×	18 0.7×	6 0.3×	10	172
Javier García‐Ceca Spain	13	28 0.4×	251 3.9×	147 2.3×	23 0.9×	6 0.3×	27	380
Jason Ruggiero United States	6	17 0.2×	35 0.5×	89 1.4×	14 0.5×	41 1.8×	6	172
Maiko Kawahara Japan	2	82 1.1×	52 0.8×	94 1.5×	28 1.0×	11 0.5×	2	333
Shinji Nito Japan	7	40 0.6×	37 0.6×	164 2.6×	11 0.4×	10 0.4×	12	230
G Cassar France	7	21 0.3×	47 0.7×	76 1.2×	40 1.5×	4 0.2×	8	195

Countries citing papers authored by Susannah Brock

Since Specialization

Citations

This map shows the geographic impact of Susannah Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susannah Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susannah Brock more than expected).

Fields of papers citing papers by Susannah Brock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susannah Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susannah Brock. The network helps show where Susannah Brock may publish in the future.

Co-authorship network of co-authors of Susannah Brock

This figure shows the co-authorship network connecting the top 25 collaborators of Susannah Brock. A scholar is included among the top collaborators of Susannah Brock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susannah Brock. Susannah Brock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Crabb, Simon J., Syed A. Hussain, Samantha Hinsley, et al.. (2022). A randomized, double blind, biomarker selected, phase II clinical trial of maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS rucaparib arm.. Journal of Clinical Oncology. 40(6_suppl). 436–436. 17 indexed citations

2.

Hockey, Peter, et al.. (2020). Measuring the working experience of doctors in training. Future Healthcare Journal. 7(3). e17–e22. 2 indexed citations

3.

James, Nicholas D., Matthew R. Sydes, M.D. Mason, et al.. (2015). 19LBA Docetaxel (Doc) +/− zoledronic acid (ZA) for hormone-naive prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476). European Journal of Cancer. 51. S719–S719. 10 indexed citations

4.

Oppitz, Matthias, Volker Möbus, Susannah Brock, & U. Drews. (2002). Muscarinic Receptors in Cell Lines from Ovarian Carcinoma: Negative Correlation with Survival of Patients. Gynecologic Oncology. 85(1). 159–164. 38 indexed citations

5.

Illidge, Tim & Susannah Brock. (2000). Radioimmunotherapy of Cancer Using Monoclonal Antibodies to Target Radiotherapy. Current Pharmaceutical Design. 6(14). 1399–1418. 17 indexed citations

6.

Zigova, Tanja, et al.. (1996). A Comparison of the Patterns of Migration and the Destinations of Homotopically Transplanted Neonatal Subventricular Zone Cells and Heterotopically Transplanted Telencephalic Ventricular Zone Cells. Developmental Biology. 173(2). 459–474. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact